Under defined differentiation conditions, human embryonic stem cells (hESCs) can be directed toward a mesendoderm (ME) or neuroectoderm (NE) fate, the first decision during hESC differentiation. Coupled with lineage-specific G1 lengthening, a divergent ciliation pattern emerged within the first 24 hr of induced lineage specification, and these changes heralded a neuroectoderm decision before any neural precursor markers were expressed. By day 2, increased ciliation in NE precursors induced autophagy that resulted in the inactivation of Nrf2 and thereby relieved transcriptional activation of OCT4 and NANOG. Nrf2 binds directly to upstream regions of these pluripotency genes to promote their expression and repress NE derivation. Nrf2 suppression was sufficient to rescue poorly neurogenic iPSC lines. Only after these events had been initiated did neural precursor markers get expressed at day 4. Thus, we have identified a primary cilium-autophagy-Nrf2 (PAN) control axis coupled to cell-cycle progression that directs hESCs toward NE.
INTRODUCTION
The core-defining property of hESCs is their dual potential to self-renew and undergo multipotent differentiation (Thomson et al., 1998) . Both the FGF and TGFb signaling pathways have been extensively studied in hESCs as key regulators of early lineage differentiation as well as stem cell self-renewal (Beattie et al., 2005; Boles et al., 2014; D'Amour et al., 2005; Greber et al., 2007; James et al., 2005; Vallier et al., 2005 Vallier et al., , 2009 Xu et al., 2002 Xu et al., , 2005 Xu et al., , 2008 Yu et al., 2011) . These signaling pathways converge upon core pluripotency factors such as OCT4 (POU5F1), NANOG, and SOX2 to regulate lineage specification (Loh and Lim, 2011) . In mouse and human ESCs, OCT4 and NANOG suppress neuroectoderm (NE) differentiation, while promoting mesendoderm (ME) derivation Wang et al., 2012) . In contrast, SOX2 drives NE fate and inhibits ME differentiation Wang et al., 2012) . However, the upstream determinants of lineage-specification at the earliest times when pluripotent cells undergo differentiation remains unknown.
Embryonic stem cells have a unique cell-cycle pattern characterized by a short G1 phase (Becker et al., 2006; Savatier et al., 1994) , which becomes lengthened upon differentiation (White and Dalton, 2005) . Recently, a FUCCI reporter system was used in human pluripotent stem cells to show that their differentiation capacity varied during progression through the cell cycle and concluded that cell fate decisions are tightly associated with the cell-cycle machinery (Pauklin and Vallier, 2013) . These authors proposed that the activity of Activin/Nodal signaling is controlled by cyclin D-CDK4/6 complex that blocks SMAD2/3 shuttling in the nucleus in late G1, thereby preventing endoderm and allowing neuroectoderm specification. However, this critical decision node is likely to require broader involvement of cellular systems to implement lineage specification.
The primary cilium is a non-motile microtubule-based organelle that acts as a cellular antenna sensing environmental cues linked to the cell cycle (Gerdes et al., 2009; Satir et al., 2010) . Specifically, the primary cilium serves as a signaling hub for Hedgehog, WNT, calcium, and PDGF pathways (Gerdes et al., 2009; Satir et al., 2010) . Recently, it was reported that ciliogenesis is differentially regulated in mouse epiblasts and extraembryonic cells (Bangs et al., 2015) . Extraembryonic cells do not have cilia while epiblasts have cilia during mouse development. However, it is still unknown how ciliogenesis is regulated in the embryonic lineage and what the exact role of primary cilia is in lineage specification.
Nuclear factor, erythroid 2-like 2 (Nrf2) is a master transcription factor for antioxidant and detoxification responses (Kensler et al., 2007; Ma, 2013) . Under homeostatic conditions, KEAP1 binds to Nrf2 protein and induces proteasomal degradation of Nrf2. When cells undergo stress, Nrf2 dissociates from KEAP1 and translocates into the nucleus to activate expression of its downstream target genes such as NAD(P)H quinone oxidoreductase (NQO1), Heme oxygenase 1 (HO1), and glutamatecysteine ligases (GCLM and GCLC) . In addition to this wellknown role of Nrf2 in orchestrating cellular defense, Nrf2 has a role in self-renewal of hESCs and adult stem cells (Hochmuth et al., 2011; Jang et al., 2014; Tsai et al., 2013) . The Nrf2 homolog skn-1 also plays a key role in early cell fate determination in Caenorhabditis elegans (An and Blackwell, 2003; Bowerman et al., 1992; Maduro et al., 2001) . However, the specific role of Nrf2 in early lineage specification of ESCs remains unknown as do the earliest harbingers of NE fate. We found that a cilium-autophagy-Nrf2 control axis serves as the core cellular machinery to connect the cell cycle to NE fate.
RESULTS

Nrf2
Regulates Early Lineage Specification by Directly Controlling OCT4 and NANOG Expression To study the earliest events of lineage determination, we differentiated NE and ME lineage cells from H9 hESCs using two well-defined induction protocols: (1) dual SMAD inhibition to induce robust NE differentiation (Chambers et al., 2009) , and (2) BMP4 and FGF2 to derive ME cells (Yu et al., 2011) . Differentiated populations underwent RNA sequencing (RNA-seq). Multidimensional scaling (MDS) plots showed clear separation by lineage ( Figure S1A ). Gene ontology analysis showed gene expression patterns that confirmed highly specific differentiation of hESCs into NE and ME cells ( Figure S1B ; Tables S1 and S2) (Huang et al., 2009) . Successful derivation of NE and ME cells was further confirmed by measuring the protein and RNA levels of lineage-specific markers (Figures S1C-S1E).
Because the fate decision to become NE or ME is the earliest divergence in three germ-layer derivation from hESCs, we examined the detailed transcriptional changes that the pluripotency gene network undergoes during differentiation into these two lineages. Hierarchical clustering based on known stem cellassociated genes grouped hESCs and ME together with both displaying high expression of stem cell genes, while NE showed generally low expression of those genes ( Figure 1A ). One exception was SOX2, which is well known to play a key role in NE derivation. These expression patterns were further confirmed in H9 and H1 hESCs by qPCR and western blot ( Figures 1B, S1F , and S1G). Downregulation of OCT4 and NANOG expression preceded PAX6 activation during NE differentiation ( Figure S1H ). We used PAX6 as a key marker for the NE lineage in this study together with other accessory markers because PAX6 is a necessary and sufficient determinant of human NE fate . These results are consistent with previous findings that OCT4 and NANOG suppress NE fate, while promoting ME differentiation Wang et al., 2012) .
Because we previously reported Nrf2 to be a pluripotency gene (Jang et al., 2014) , we tested whether Nrf2 played a role in controlling the divergent expression of pluripotency genes during early cell fate decision. First, we analyzed Nrf2 activity during differentiation by looking at the expression of well-known Nrf2 target genes (Gorrini et al., 2013) . Interestingly, hierarchical clustering of RNA-seq data again clustered hESCs and ME cells together with high expression of Nrf2 target genes in both cell types ( Figure 1C ). In contrast, NE cells showed low expression of Nrf2 target genes ( Figure 1C ). This clustering of hESCs and ME cells distinctly from NE cells mirrored the expression pattern of stem cell-associated genes ( Figure 1A ). These patterns were further validated in both H9 and H1 hESCs by qPCR (NQO1, HO1, GCLM, ME1) and western blot (NQO1) ( Figures 1B, 1D , and S2A). Consistent with the expression pattern of Nrf2 target genes, Nrf2 protein level was specifically downregulated in NE cells ( Figure 1E ). To test how Nrf2 activity is modulated during spontaneous differentiation of hESCs, we analyzed the expression pattern of the Nrf2 target gene, NQO1, in H9 cells differentiated by FGF2 deprivation. This method of differentiation will induce both NE and ME in the dish. Cells with high NQO1 expression also showed high OCT4 and NANOG expression (Figure S2B ), further suggesting a correlation between Nrf2 activity and the expression levels of OCT4 and NANOG. We also checked the expression of Nrf2 target genes in the Cortecon database, which provides a temporal transcriptome profile of in vitro human cerebral cortex development (van de Leemput et al., 2014) . Consistent with our results, the expression levels of NQO1, HO1, GCLM, and ME1 dramatically decrease during early neural differentiation of hESCs ( Figure S2C ). Next, we analyzed the timing of Nrf2 target gene downregulation during NE differentiation. After transient expression of some Nrf2 target genes on day 1 of differentiation, the expression of all three Nrf2 target genes started to decline between days 1 and 2 ( Figure 1F ). A significant increase in PAX6 expression was first detected at day 4 ( Figure 1G ). Collectively, these data suggest that Nrf2 activity positively correlates with the expression of OCT4 and NANOG during early lineage specification. More importantly, downregulation of Nrf2 activity was specific to NE fate and preceded expression of the NE lineage marker PAX6.
To test whether Nrf2 directly controls OCT4 and NANOG expression, Nrf2's binding profile was analyzed using chromatin immunoprecipitation (ChIP). To validate the Nrf2 ChIP assay, we first probed the NQO1 gene locus and confirmed that Nrf2 bound to the known Nrf2 binding region upstream of the transcription start site (TSS), but not to exon2 of NQO1 ( Figures 1H and 1I ). Based on the Nrf2 binding motif sequence, we identified five potential Nrf2 binding sites around the TSS of OCT4 and one potential binding site around the TSS of NANOG ( Figure 1H ). ChIP-PCR results showed that Nrf2 bound to multiple sites in the OCT4 gene locus and one site 6 kb upstream of the NANOG TSS ( Figures 1H and 1I ). Nrf2 binding was not detected in control regions, the downstream region of OCT4 and intron 1 of NANOG ( Figures 1H and 1I ). To test functionally whether Nrf2 controls the expression of OCT4 and NANOG during early differentiation, we downregulated Nrf2 using two short hairpin RNAs (shRNAs) with different knock-down (KD) efficiencies (70% KD with shRNA #1 and 25% KD with shRNA #2) ( Figure S2D ). Nrf2 inhibition by shRNAs facilitated the downregulation of OCT4 and NANOG expression during differentiation with different efficacies corresponding to the shRNA KD efficiencies ( Figure 1J ). These results were further confirmed by overexpressing KEAP1 to downregulate Nrf2 ( Figure S2E ). Cells transduced with KEAP1 lentiviral vectors showed low levels of OCT4 and NANOG proteins during differentiation ( Figure S2F ). In parallel, we also tested the effects of Nrf2 activators on the expression of OCT4 and NANOG. Nrf2 activators, t-BHQ and sulforaphane, release Nrf2 proteins from KEAP1 and induce nuclear translocation of Nrf2. Nrf2 activation delayed the downregulation of OCT4 and NANOG expression during hESC differentiation ( Figures 1K, S2G , and S2H). Collectively, these results suggest that Nrf2 directly controls OCT4 and NANOG expression during early differentiation of hESCs.
Given the important roles of OCT4 and NANOG as early lineage specifiers, we investigated whether Nrf2 suppression was required for NE differentiation by overexpressing Nrf2 (Figure S2E) . Upon NE differentiation, Nrf2 overexpressing cells (GFP + cells) failed to activate PAX6 expression, suggesting that Nrf2 suppresses NE derivation ( Figure 1L ). These data were confirmed in H1 cells, another hESC line ( Figure S2I ). Furthermore, Nrf2 activation via t-BHQ and sulforaphane also strongly suppressed expression of prominent NE markers (PAX6, OTX1, OTX2, LHX5, and ZBTB16), while further promoting expression of ME lineage markers (GATA6 and HAND1) (Figures 1K, S2H, and S2J) . Other ME markers, Brachyury and SOX17, were not expressed in our experimental timeline during hESC differentiation by FGF2 deprivation. However, we observed the activation of Brachyury and SOX17 when ME differentiation was promoted by t-BHQ ( Figure S2J ). Nrf2 knock-down diminished this effect of t-BHQ, thereby supporting the effect of the chemical activator as Nrf2-dependent ( Figure S2K ). Furthermore, knock-down of OCT4 and NANOG by small interfering RNAs (siRNAs) almost completely rescued the phenotype induced by t-BHQ treatment, suggesting that Nrf2 activation suppresses NE fate through OCT4 and NANOG (Figures S2L and S2M) . To test whether Nrf2 inhibition promotes NE derivation, we reduced Nrf2 activity via shRNAs during differentiation. Nrf2 knock-down greatly increased expression of NE lineage markers while suppressing ME markers (Figures 1M and S2O) . Because Nrf2 shRNA #1 targeted the 3 0 UTR, we rescued the phenotype of Nrf2 inhibition by overexpressing the Nrf2 coding sequence. Knock-down of Nrf2 by shRNA significantly increased PAX6 + cell derivation upon differentiation, which was blocked by Nrf2 overexpression ( Figure S2N ). Notably, Nrf2 inhibition further promoted the activation of NE markers even in the highly (M) qPCR analysis of NE and ME markers in shRNAs expressing H9 cells that were differentiated by FGF2 deprivation (n = 4). Error bars represent SD. *p < 0.01, #p < 0.05 (Student's t test), t-BHQ, tert-butylhydroquinone. NE and ME cells were differentiated for 5 days unless otherwise specified. See also Figures S1 and S2 and Tables S1 and S2. neurogenic differentiation condition (Dual SMAD inhibition), emphasizing the key role of Nrf2 inhibition in NE derivation (Figure S2P) . Overall, these data suggest that Nrf2 represses NE fate by directly controlling OCT4 and NANOG expression and that Nrf2 suppression is a prerequisite for successful NE induction.
Nrf2 Activity Predicts NE Differentiation in Induced Pluripotent Stem Cells, and Nrf2 Suppression Rescues Neural Fate Since induced pluripotent stem cells (iPSCs) were established, many studies have shown that iPSC lines have highly variable differentiation potentials (Kajiwara et al., 2012; Kim et al., 2011; Koyanagi-Aoi et al., 2013) . To ensure efficacy of iPSC differentiation for potential stem cell therapeutics and better understand the regulatory hierarchy in neural differentiation, it is important to find factors that are reliably predictive of neurogenic potential. Given the important role of Nrf2 in early hESC differentiation, we hypothesized that the levels of Nrf2 activity in iPSCs may predict their differentiation potential. We analyzed eight well-characterized iPSC lines (three human and five chimpanzee lines) derived using the same reprogramming method ( Figure S3A ) (Gallego Romero et al., 2015) . Because chimpanzee iPSCs share similar morphology and global transcriptome profiles with human iPSCs (Fujie et al., 2014) , we included the chimpanzee iPSCs in our analysis. The expression of Nrf2 target genes, NQO1 and GCLM, was highly variable across the iPSC lines (Figure 2A) . However, the level of Nrf2 mRNA did not show high variation among the iPSC lines, supporting the observation that Nrf2 activity is mainly controlled post-transcriptionally ( Figure S3B ). To measure each line's early differentiation potential, iPSCs were spontaneously differentiated by FGF2 deprivation for 7 days. The expression levels of Nrf2 target genes in iPSCs inversely correlated with the PAX6 expression levels in their differentiated progenies (p = 0.0024 for NQO1, p = 0.0093 for GCLM) (FigFigure 2 . Nrf2 Activity Determines Neurogenic Potential of iPSCs (A) qPCR analysis of Nrf2 target genes and SOX2 across undifferentiated iPSCs. PAX6 expression was analyzed by qPCR in iPSCs differentiated for 7 days by FGF2 deprivation. (B) The most poorly neurogenic hiPSC lines were transduced with lentiviral vector expressing Nrf2 shRNA. qPCR analysis of NQO1 and PAX6 expression as described in (A). (C) The expression of NE and ME markers was measured by qPCR (n = 4). Error bars represent SD. *p < 0.01 (Student's t test). See also Figure S3 . ure 2A), suggesting that iPSCs with lower Nrf2 activity are more neurogenic. We also observed a negative correlation between NQO1 expression in iPSCs and ZBTB16 (NE marker) expression in differentiated progenies with exception of one outlier ( Figure S3C ). To clarify whether Nrf2 activity in iPSCs is related to NE/ ME differentiation bias or general differentiation efficiency of iPSCs, we tested the relationship between Nrf2 activity and ME differentiation potential. GATA6 expression was analyzed as a marker for ME. In contrast to NE markers, GATA6 expression in differentiated iPSCs showed a positive correlation with NQO1 expression in iPSCs when human and chimpanzee iPSC lines were separated ( Figure S3D ), which might be attributed to species-specific expression of GATA6. These results suggest that Nrf2 activity is related to differentiation propensity of iPSC lines between NE and ME fates and further confirm our finding that Nrf2 represses NE differentiation and promotes ME differentiation. As expected, SOX2, which is active in the pluripotent state and is a NE lineage specifier, was not highly variable across iPSC lines and did not show any significant correlation with induction of PAX6 expression during differentiation (p = 0.1154) (Figure 2A ). Neither did we observe any predictability for neurogenic potential using OCT4 and NANOG mRNA levels ( Figure S3B ). These data suggest that Nrf2 activity levels are highly predictive of NE differentiation potential in contrast to core pluripotency gene products. Nrf2 inhibition is also sufficient to rescue poorly neurogenic iPSC lines. We suppressed Nrf2 activity using shRNA in two human iPSC lines that were identified as the most poorly neurogenic. Notably, decreasing Nrf2 activity restored the balance of differentiation in those iPSCs with increased NE and decreased ME markers ( Figures 2B and 2C) , further supporting the key role of Nrf2 in early lineage determination.
Lineage-Specific Regulation of Autophagy Controls Nrf2 Activity To study how Nrf2 activity is controlled in a lineage-specific manner, we investigated the RNA levels of Nrf2 and KEAP1, a key repressor of Nrf2, and the levels of intracellular reactive oxygen species. However, we did not see any significant changes that match lineage-specific Nrf2 activity (Figures S4A and S4B) .
Because a growing body of evidence suggests autophagy plays an important role in controlling Nrf2 activity (Ichimura et al., 2013; Komatsu et al., 2010; Lau et al., 2010) , we measured autophagy activity during differentiation. We first generated an autophagy reporter hESC line that stably expressed RFP-LC3, which allowed us to visualize autophagosomes. hESCs expressing RFP-LC3 were then differentiated into the NE or ME lineage. The number of autophagosomes (RFP-LC3 puncta) was dramatically increased in NE cells, while remaining low in ME lineage cells ( Figure 3A) . To more specifically analyze the dynamics of autophagosome formation and maturation, we took advantage of an autophagy tandem reporter mRFP-GFP-LC3 where autophagosomes appear as yellow puncta while autolysosomes are red due to loss of GFP signal (Kimura et al., 2007) . NE lineage cells showed a dramatic increase in total number of autophagic vacuoles between day 1 and 2 of differentiation, with most vacuoles becoming autolysosomes (red puncta) (Figures 3B and   3C ). Interestingly, both hESCs and ME cells not only had a lower total number of autophagic vacuoles but also a higher percentage of the vacuoles were autophagosomes (yellow puncta), suggesting a reduced frequency of autophagosome-lysosome fusion ( Figure 3B ). We further measured autophagy activity by analyzing the protein level of p62 (SQSTM1), a substrate for autophagic degradation. Interestingly, p62 can regulate Nrf2 activity positively by inactivating KEAP1 (Ichimura et al., 2013; Komatsu et al., 2010; Lau et al., 2010) . Compared to ME cells, p62 protein level was significantly decreased in NE cells (Figure 3D) , which further supports that autophagy activity is selectively increased in NE cells. Additionally, p62 RNA level did not dramatically differ between samples in the whole transcriptome data ( Figure S4C ), thereby attributing the NE-specific decrease in p62 expression primarily to accelerated degradation by autophagy. Furthermore, NE cells expressed a high level of KEAP1, which is consistent with their low p62 protein level and low Nrf2 activity ( Figure 3D ). Inhibition of proteasomal degradation in NE cells induced Nrf2 nuclear accumulation and increased Nrf2 activity, suggesting that Nrf2 protein is actively degraded (Figures S4D and S4E) . We analyzed the timing of p62 protein expression during NE differentiation and found that the p62 protein level started to decline between day 1 and 2 ( Figure 3E ). This pattern matches that of Nrf2 activity, with both preceding PAX6 activation.
To test directly whether autophagy regulates Nrf2 activity during NE differentiation, we first inhibited autophagy using a chemical inhibitor, 3-methyladenine (3-MA). 3-MA inhibits class III PI3K activity that is important for autophagy induction. 3-MA treatment significantly increased the level of p62 protein and induced nuclear translocation of Nrf2 proteins and concomitant activation of Nrf2 target genes during NE differentiation ( Figures  3F, 3G , and S4F). These results were confirmed by siRNAs that targeted key autophagy genes (ATG7 and ATG14) ( Figures 3H,  S4G , and S4H). Furthermore, autophagy inhibition by 3-MA during spontaneous differentiation of hESCs was sufficient to block the downregulation of Nrf2 target genes ( Figure 3I ). Having shown that suppression of Nrf2 is an important event in NE differentiation, we hypothesized that lineage-specific regulation of autophagy activity accordingly plays an important role in early differentiation. In both spontaneous and NE-directed differentiation, autophagy inhibition strongly suppressed the expression of early NE markers ( Figures 3J, 3K, and S4I) . Notably, autophagy inhibition activated expression of some ME genes ( Figures 3J  and 3K ). Nrf2 inhibition by siRNA partially rescued the autophagy inhibition phenotype (Figures 3L and S4J) . Overall, our data suggest that autophagy is activated in a lineage-specific manner and controls early hESC differentiation by regulating Nrf2 activity.
The Primary Cilium Is Essential for Activation of Autophagy during NE Differentiation
Since many different pathways could converge to regulate autophagy, we revisited the whole transcriptome data and performed a gene ontology analysis with genes differentially expressed between NE and ME cells (Wang et al., 2013) . One might expect an enrichment of genes related to the mammalian target of rapamycin (mTOR) pathway, which is a well-known negative regulator of autophagy; however, these genes were neither up nor downregulated in the NE lineage. Interestingly, we found a significant enrichment of primary cilium-related genes that were upregulated in the NE lineage, but not in the ME lineage ( Figure 4A ). Recently, it was reported that the primary cilium is essential for the activation of starvation-induced autophagy in mouse fibroblasts, kidney epithelial cells, and retinal ganglion cells (Pampliega et al., 2013) . Because hESCs have functional primary cilia (Kiprilov et al., 2008) , we hypothesized that primary cilia may play a role in sensing differentiation cues and activating autophagy during NE differentiation. First, we analyzed the percentage of ciliated cells in hESC, NE, or ME populations by acetylated tubulin staining. Acetylated tubulin + cilia were confirmed to have g-tubulin + basal bodies ( Figure S5A ). Both hESC and ME populations had a low percentage of ciliated cells while 70% of NE cells were ciliated ( Figures 4B and S5B) , which was consistent with the RNA-seq data enrichment. This ciliation pattern was confirmed using another cilia reporter, Arl13b-GFP (Figure S5C) . Lastly, we found the increased percentage of ciliated cells occurred between day 0 and 2 of NE differentiation (Figure 4C) , before autophagy activation and well before the expression of PAX6 during NE differentiation.
To test whether increased ciliogenesis in the NE lineage was necessary for autophagy activation, we treated differentiating cells with siRNAs targeting key ciliary genes, IFT20, IFT88, and KIF3A ( Figure S5D ). siRNA treatment significantly decreased the percentage of ciliated cells during NE differentiation (Figure S5E) . Reduced ciliogenesis strongly blocked upregulation of autophagosome formation and p62 degradation during the NE differentiation procedure ( Figures 4D, 4E , and S5F), confirming the primary cilium-autophagy functional connection in this context. Furthermore, reduced ciliogenesis impaired activation of PAX6 and other early NE markers (Figures 4F, 4G, and S5G) . Consistent with the important role of autophagy in suppressing Nrf2 activity, reduced ciliogenesis by IFT20 siRNA hampered the decrease of Nrf2 activity during NE differentiation ( Figure S5H ) and Nrf2 inhibition by shRNA was sufficient to block the effect of IFT20 siRNA on NE differentiation ( Figure S5I ). In contrast to NE differentiation, treatment of siRNAs targeting IFT20, IFT88, and KIF3A did not show a dramatic effect on Brachyury + ME cell derivation during ME differentiation ( Figure S5J ), consistent with a low percentage of ciliation in ME lineage cells. These data suggest that primary cilium-mediated autophagy activation is necessary for NE differentiation.
Although we showed that inhibition of cilia-mediated autophagy activation blocked proper NE differentiation, we also tested whether activation of cilia and autophagy could suppress Nrf2 activity and de-repress NE fate. Because serum starvation is a well-known physiological condition that activates both ciliogenesis and autophagy, we compared the effects of high (20% knockout serum replacement [KOSR] ) and low (2% KOSR) serum treatment on hESC differentiation. As expected, low serum strongly activated ciliogenesis and autophagy (Figures S6A and S6B) . Interestingly, low serum treatment further decreased Nrf2 activity and OCT4 and NANOG expression (Figures S6C and S6D ) and dramatically increased expression of PAX6 at the expense of ME marker expression in differentiating cells ( Figures S6E and S6F) . Serum starvation for just 5 hr was sufficient to promote NE derivation while suppressing ME differentiation ( Figure S6G ). Furthermore, Nrf2 inhibition blocked the NE-promoting effect of low serum ( Figure S6H ), highlighting the important role of the primary cilia-autophagy-Nrf2 (PAN) axis in lineage specification. Taken together, these results suggest that ciliogenesis is differentially regulated during early lineage specification and that the primary cilium via its control over autophagy, plays a key role in NE differentiation.
Cell Cycle Controls Lineage-Specific Ciliogenesis
Ciliogenesis is tightly linked to cell-cycle progression (Pan and Snell, 2007; Plotnikova et al., 2009 ) and cell-cycle lengthening in G1 is linked to embryonic stem cell and neural and hematopoietic progenitor cell differentiation (Calegari and Huttner, 2003; Lange and Calegari, 2010; Lange et al., 2009) . During early G1 phase, cells start to assemble the primary cilium. The cilium matures by mid/late G1, starts to disassemble during G2, and is absent during M phase. To test whether the cell-cycle progression pattern accounts for the dramatic differences in ciliation patterns during lineage specification, we analyzed cell-cycle patterns during differentiation by propidium iodide staining. Consistent with previous reports, hESCs showed a unique cell-cycle pattern with a low percentage of G1 cells (25%) and high percentage of G2/M cells (40%) ( Figure 5A ). Upon differentiation, ME lineage cells maintained this unique cell-cycle pattern, while NE cells showed a contrasting pattern with a high percentage of G1 cells (48%) and low percentage of G2/M cells (22%) ( Figure 5A ). These cell-cycle patterns were confirmed in H1 hESCs ( Figure S7A ) and correlated well with our observation of a high ciliation percentage in NE cells ( Figure 4B) . Furthermore, the G1 lengthening during NE differentiation mirrored changes in the ciliation pattern with a significant shift that occurred between day 0 and day 2 ( Figure 5B ). Because we found that Nrf2 inhibition is a robust and efficient way to induce NE fate from hESCs, the cell-cycle and ciliation patterns were analyzed using an Nrf2 neural induction protocol. Nrf2 inhibition during differentiation further increased the percentages of G1 cells and ciliated cells ( Figures S7B and S7C) , confirming that these changes are features of early NE derivation.
To validate the cell-cycle patterns in live cells, we used the FUCCI cell-cycle reporter that expresses red fluorescence in mid/late G1 and green fluorescence in S/G2/M (Sakaue- Sawano et al., 2008; Streichan et al., 2014) . Consistent with the data from propidium iodide staining, an increased number of red fluorescent cells was observed even at day 1 of NE differentiation, while no significant change was detected during ME differentiation ( Figures 5C and S7D ). These data suggest that the lengthening of mid/late G1 occurs at a very early stage of NE derivation. To improve the time resolution of early cell-cycle changes, we traced FUCCI hESCs for 24 hr after NE induction by time-lapse microscopy ( Figure 5D ; Movie S1). A transient increase in the number of red cells occurred at 5 hr, and a definitive lengthening of mid/late G1 occurred at 14 hr after differentiation. Interestingly, lengthening of mid/late G1 appeared to occur coordinately within a short time window (12-16 hr). (E and F) Western blot for p62 expression (day 3 after differentiation) (E) and immunofluorescence of PAX6 (day 5 after differentiation) (F) in H9 cells transfected with siRNAs and induced to differentiate to NE cells. Scale bar, 100 mm. (G) qPCR analysis of NE marker expression in H9 cells transfected with siRNAs and induced to differentiate to NE cells (n = 4). Error bars represent SD. *p < 0.01, #p < 0.05 (Student's t test). NE and ME cells were differentiated for 5 days unless otherwise specified. See also Figures S5 and S6 and Tables S1 and S2. Given the tight relation between the cell cycle and ciliogenesis, we tested whether cell-cycle modulation could induce changes in ciliation pattern in hESCs. Sixteen hour treatment with PD0332991, a highly specific CDK4/6 inhibitor, shifted the cell-cycle pattern toward G1 phase at the expense of G2/M phase ( Figure S7E ). The cell-cycle pattern change induced by PD0332991was sufficient to increase the percentage of ciliated cells in hESCs ( Figure 5E ). These results were further confirmed by 10058-F4, a c-Myc-Max dimerization inhibitor (Figures S7F and S7G) . Finally, we examined whether the increased percentage of ciliated hESCs induced by G1 lengthening at the onset of differentiation could affect differentiation propensity of hESCs toward NE ( Figure 5F ). Sixteen hour-treatment of PD0332991 before differentiation further decreased the expression of Nrf2 target genes and OCT4 and NANOG during spontaneous differentiation ( Figures S7H and S7I) , which consequently increased NE marker expression and suppressed ME marker expression ( Figures 5F, 5G , and S7J). These results suggest that G1 lengthening and concomitant increase of ciliation is not a driver for general hESC differentiation, but a specific determinant for NE fate. Treatment of 10058-F4 also produced more PAX6 + NE cells during hESC differentiation ( Figure S7K ), thereby validating the data from PD0332991. siRNAs targeting ciliary and autophagy genes reversed the phenotype induced by PD0332991 ( Figures S7L  and S7M ). Overall, these results suggest that lineage-specific cell-cycle patterns contribute to cell fate acquisition by establishing differential ciliation patterns during early hESC lineage specification.
DISCUSSION
The emergence of NE cells during hESC differentiation can readily be detected by neural progenitor markers, most demonstrably by PAX6. We found a set of cellular systems that herald the neural lineage before prominent NE markers appear. The earliest implementation of NE differentiation involves restructuring of the cell cycle. A prominent change is lengthening of G1, the gap phase in which the primary cilium emerges. Previously G1 lengthening was thought to be related to general differentiation of stem cells (Lange and Calegari, 2010; White and Dalton, 2005) . However, we found that G1 lengthening occurs specifically during NE differentiation, but not during ME differentiation (F and G) Immunofluorescence of PAX6 (F) and qPCR analysis of NE and ME markers (G) in differentiated H9 cells treated with PD0332991for 16 hr prior to differentiation. *p < 0.01(Student's t test). NE and ME cells were differentiated for 5 days unless otherwise specified. See also Figure S7 and Movie S1.
at the early decision point of hESC differentiation ( Figure 5A ), suggesting a key role of G1 elongation in lineage determination. Pauklin and Vallier (2013) reported that hESCs in the early G1 phase predominantly activate ME lineage genes upon differentiation while hESCs in late G1 exclusively activate NE lineage genes. The important role of the primary cilium in cell fate decision contributes a mechanistic insight to this finding. During the cell cycle, the primary cilium matures by mid/late G1 and thereby, enables cells to drive an NE fate. Consistent with this observation, we showed that increased ciliation by PD0332991 and 10058-F4 at the onset of hESC differentiation is sufficient to activate the PAN axis and promote NE fate. In contrast, Pauklin and Vallier (2013) reported a result that continuous CDK4/6 inhibition by PD0332991 during hESC differentiation induced G1 lengthening but facilitated ME differentiation. However, continuous cell-cycle inhibition in that experimental setting did not separate the effect of G1 lengthening from general proliferation inhibition. This apparent discrepancy is based on how cell-cycle inhibition is experimentally manipulated, and our experiment clarifies the role of lengthened G1 in hESC lineage specification.
Recently, it was shown that OCT4 and SOX2 can be replaced during cellular reprogramming by mesendoderm and ectoderm specifiers, respectively (Montserrat et al., 2013; Shu et al., 2013) . This result suggested that pluripotency is a state of optimized balance between lineage specifiers, but how this balance is tipped toward one fate or the other may arise from the integration of the PAN regulatory axis that emerges with the lengthening of G1. We found that Nrf2 plays a key role in controlling lineagespecific segregation of OCT4 and NANOG expression by directly binding near their transcription start sites. Of particular interest is the post-transcriptional regulation of Nrf2 activity, which positions Nrf2 outside and likely upstream of the OCT4/NANOG/ SOX2 transcriptional feedback network for pluripotency. Nrf2 transcriptional control over downstream pluripotency genes and its own post-transcriptional control in the cytoplasm provide a systems-wide link for environmental and cellular control to operate over NE differentiation distinctly from controls that are strictly confined to the genome and its transcription. This mechanism may allow Nrf2 to alter pluripotency gene expression efficiently and guide lineage-specification that ultimately and further downstream requires the establishment of complex patterns of epigenetic marks (Aloia et al., 2013; Hosogane et al., 2013; Riising et al., 2014; Yuan et al., 2012) . Interestingly, we found that Nrf2 forms a feedback loop with the upstream regulators, the cell cycle and primary cilia ( Figures S7B and S7C) . We assume that this feedback loop reinforces the PAN axis and thus stably secures NE fate. Because G1 lengthening also occurs during differentiation of neural and hematopoietic stem cells (Lange and Calegari, 2010) , the PAN axis may serve as a key regulator of further fate decisions in those cells.
EXPERIMENTAL PROCEDURES
Cell Culture H9 (WiCell) and H1 (WiCell) cells were maintained on Matrigel (BD Biosciences) in mTeSR1 medium (Stem Cell Technologies). H9 and H1 cells were passaged by mechanical dissociation every 5-6 days. Human and chimpanzee iPSC lines (provided by Dr. Yoav Gilad at University of Chicago) were maintained on Matrigel with Essential 8 medium (Life Technologies). HEK293T cells (CRL-11268) were purchased from ATCC and maintained in DMEM supplemented with 10% fetal bovine serum.
hESC Differentiation For spontaneous differentiation, hESCs and iPSCs were seeded onto Matrigelcoated plates and induced to differentiate in hESC culture medium (DMEM/ F12, 15% knockout serum replacement, MEM non-essential amino acid solution, and 0.1 mM b-mercaptoethanol) without FGF2. H9 and H1 hESCs were differentiated into NE cells using the dual SMAD inhibition method (Chambers et al., 2009) . Briefly, hESCs were dissociated using Accutase (Life Technologies) and plated onto Matrigel-coated plates with ROCK inhibitor (Y-27632, Millipore). Upon reaching high confluency (80%-90%), cells were induced to differentiate with hESC culture medium containing NOGGIN (200 nM, Pepro Tech) and SB431542 (10 mM, Tocris Bioscience). For ME differentiation, cells were dissociated using Accutase, plated onto Matrigel-coated plates with ROCK inhibitor (Y-27632), and induced to differentiate with mTeSR1 medium containing 5 ng/ml BMP4 (R&D) (Yu et al., 2011) .
Immunofluorescence Cells were fixed with 4% paraformaldehyde, permeabilized with 0.25% Triton X-100, and then blocked with 10% FBS in PBS. Samples were stained with primary antibodies for OCT4 (Santa Cruz), NANOG (R&D), SOX2 (Millipore), PAX6 (Santa Cruz), Brachyury (R&D), acetylated tubulin (Sigma), g-tubulin (Sigma), NQO1 (Cell Signal), Nrf2 (Abcam), and KEAP1 (Millipore) overnight at 4 C.
Cells were then incubated in secondary antibodies Alexa Fluor 488-donkey anti-mouse IgG, Alexa Fluor 488-donkey anti-rabbit IgG, Alexa Fluor 488-donkey anti-goat IgG, Alexa Fluor 555-donkey anti-rabbit IgG, and Alexa Fluor 555-donkey anti-mouse IgG (Life Technologies) for 1 hr at room temperature. Images were acquired using Olympus IX71 fluorescence microscope with MetaMorph software (Molecular Devices).
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